Pharmacovigilance system in Saudi Arabia

被引：34

作者：

Alshammari, Thamir M. ^{[1
,2
]}

Alshakka, Mohammed ^{[3
]}

Aljadhey, Hisham ^{[2
,4
]}

机构：

[1] Univ Hail, Coll Pharm, POB 2457, Hail 11451, Saudi Arabia

[2] King Saud Univ, Medicat Safety Res Chair, Riyadh, Saudi Arabia

[3] Aden Univ, Coll Pharm, Aden, Yemen

[4] King Saud Univ, Coll Pharm, Riyadh, Saudi Arabia

来源：

SAUDI PHARMACEUTICAL JOURNAL | 2017年 / 25卷 / 03期

关键词：

ADRs; Drug safety; Healthcare system; Pharmacovigilance; Risk management plan; COMMUNITY PHARMACISTS KNOWLEDGE; CARE; SAFETY; FUTURE;

D O I：

10.1016/j.jsps.2016.09.008

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Pharmacovigilance plays an important role in ensuring that patients are receiving safe drugs. In Saudi Arabia, Saudi Food and Drug Authority, health institutions, marketing authorization holders and healthcare professional are involved in pharmacovigilance activities regardless of the level of the involvement. Although pharmacovigilance is well established in developed nations and it is considered a new concept in Saudi Arabia. It is a collective effort from various stakeholders to make pharmacovigilance successful toward promoting safe and effective use of medicines among the population. However, the practice of pharmacovigilance still needs more attention especially from marketing authorization holders and healthcare professionals. The aim of this review was to describe the current situation of pharmacovigilance in Saudi Arabia and the activities that have been conducted by the stakeholders. (C) 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.

引用

页码：299 / 305

页数：7